We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+46.56%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$153M
AUM Growth
+$44M
Cap. Flow
+$5.06M
Cap. Flow %
3.31%
Top 10 Hldgs %
41.14%
Holding
109
New
15
Increased
25
Reduced
38
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 64.34%
2 Technology 12.79%
3 Communication Services 8.46%
4 Industrials 4.04%
5 Consumer Staples 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOR
26
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$2.2M 1.44%
+1,654
New +$2.43M
VG
27
DELISTED
Vonage Holdings Corporation
VG
$2.01M 1.31%
156,025
+1,975
+1% +$24K
ATRS
28
DELISTED
Antares Pharma, Inc.
ATRS
$1.92M 1.25%
480,783
+254,250
+112% +$823K
ELUT icon
29
Elutia
ELUT
$38.6M
$1.9M 1.24%
+139,375
New +$1.74M
QUMU
30
DELISTED
Qumu Corp.
QUMU
$1.89M 1.23%
235,860
-125,140
-35% -$659K
PFE icon
31
Pfizer
PFE
$146B
$1.82M 1.19%
49,548
-1,437
-3% -$52.7K
XGN icon
32
Exagen
XGN
$162M
$1.75M 1.14%
132,355
+12,000
+10% +$169K
SHSP
33
DELISTED
SharpSpring, Inc.
SHSP
$1.72M 1.12%
+105,325
New +$1.47M
ASPU
34
DELISTED
ASPEN GROUP, INC.
ASPU
$1.64M 1.07%
147,250
-5,500
-4% -$61K
PFIE
35
DELISTED
Profire Energy, Inc
PFIE
$1.58M 1.03%
1,853,989
+833,500
+82% +$664K
CSLT
36
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.56M 1.02%
1,204,000
-21,750
-2% -$24.5K
BLFS icon
37
BioLife Solutions
BLFS
$1.62B
$1.48M 0.97%
37,000
-26,650
-42% -$909K
TGT icon
38
Target
TGT
$67.1B
$1.43M 0.93%
8,079
-450
-5% -$75.1K
ABBV icon
39
AbbVie
ABBV
$438B
$1.31M 0.85%
12,188
-900
-7% -$86.5K
T icon
40
AT&T
T
$157B
$1.15M 0.75%
53,065
-993
-2% -$21.4K
MMM icon
41
3M
MMM
$94.2B
$1.15M 0.75%
7,841
+837
+12% +$119K
INTZ
42
DELISTED
INTRUSION INC NEW
INTZ
$1.07M 0.7%
+60,500
New +$1.07M
VZ icon
43
Verizon
VZ
$189B
$1.04M 0.68%
17,725
+1,850
+12% +$110K
AVGR
44
DELISTED
Avinger, Inc. Common Stock
AVGR
$1.03M 0.67%
7,791
-47
-0.6% -$4.26K
BMY icon
45
Bristol-Myers Squibb
BMY
$130B
$1.02M 0.67%
16,450
-300
-2% -$18.4K
MRK icon
46
Merck
MRK
$323B
$1M 0.66%
12,864
-524
-4% -$40.1K
CIEN icon
47
Ciena
CIEN
$57.2B
$965K 0.63%
18,250
STRM
48
DELISTED
Streamline Health Solutions
STRM
$945K 0.62%
40,390
+11,473
+40% +$266K
QUIK icon
49
QuickLogic
QUIK
$250M
$931K 0.61%
245,602
-113,386
-32% -$353K
VMAR icon
50
Vision Marine Technologies
VMAR
$4.86M
0

Similar funds

Perkins Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Perkins Capital Management held 109 positions worth $153M, up 40% from $109M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Perkins Capital Management deployed $5.06M of net new capital in Q4 2020, opening 15 new positions and adding to 25 existing holdings. Its largest new stake was Cantaloupe: 254,325 shares worth $2.67M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 65% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Magnite, an estimated $1.29M trimmed.

  • Perkins Capital Management's largest Q4 2020 buy was Cantaloupe: 254,325 shares worth $2.67M.
  • Perkins Capital Management added most to Antares Pharma, Inc. in Q4 2020, an estimated $823K increase.
  • Perkins Capital Management's biggest Q4 2020 reduction was Magnite, cutting an estimated $1.29M.
  • Perkins Capital Management fully exited Digital Turbine in Q4 2020, selling an estimated $989K.
  • Perkins Capital Management's ten largest holdings make up 41% of its $153M portfolio in Q4 2020.
  • Perkins Capital Management opened 15 new positions and closed 9 in Q4 2020.
  • Perkins Capital Management's portfolio value rose 40% quarter-over-quarter to $153M.

Based on Perkins Capital Management's 13F filing for Q4 2020, filed 9 Feb 2021.